Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies
Clinical trial NCT03366350 · UNKNOWN
Trial details
- NCT number
- NCT03366350
- Sponsor
- Wuhan Sian Medical Technology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-15
- Primary completion
- 2021-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.